"10.1371_journal.pone.0108046","plos one","2014-09-29T00:00:00Z","Wouter Wegdam; Carmen A Argmann; Gertjan Kramer; Johannes P Vissers; Marrije R Buist; Gemma G Kenter; Johannes M F G Aerts; Danielle Meijer; Perry D Moerland","Department of Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Clinical Proteomics Group, Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Waters Corporation MS Technologies Center, Manchester, United Kingdom; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","Conceived and designed the experiments: WW DM PDM MRB JMFGA GGK. Performed the experiments: WW DM GGK. Analyzed the data: PDM CAA WW DM. Contributed reagents/materials/analysis tools: JMFGA. Wrote the paper: WW DM CAA PDM. Provided technical support during the mass-spectrometry measurements, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript: JPV.","Johannes P. Vissers is employed by Waters Corporation. The methods described in the manuscript make use of the following Waters Corporation marketed products: a nanoAcquity system, a Synapt G2 MS mass spectrometer, ProteinLynx GlobalSERVER (PLGS) v2.5, Mass Prep Quantitation standard, and RapiGest SF. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","09","Wouter Wegdam","WW",9,TRUE,6,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
